keyword
MENU ▼
Read by QxMD icon Read
search

intragastric balloon

keyword
https://www.readbyqxmd.com/read/29127916/laparoscopic-management-of-a-small-bowel-obstruction-secondary-to-elipse-intragastric-balloon-migration-a-case-report
#1
Saud Al-Subaie, Hamad Al-Barjas, Salman Al-Sabah, Saud Al-Helal, Ashraf Alfakharani, Salah Termos
INTRODUCTION: The Elipse™ intragastric balloon (IGB) for weight loss is a swallowable capsule that is filled with 550mL of fluid and resides in the stomach for four months before being excreted from the gastrointestinal tract. Although initial data showed that use of this device is safe and free from serious complications, we report for the first time the successful management of an Elipse™ IGB-related adverse event. PRESENTATION OF CASE: A 41-year-old woman presented to our emergency department following two days of abdominal pain, vomiting, and constipation...
November 8, 2017: International Journal of Surgery Case Reports
https://www.readbyqxmd.com/read/29108896/brazilian-intragastric-balloon-consensus-statement-bibc-practical-guidelines-based-on-experience-of-over-40-000-cases
#2
Manoel Galvao Neto, Lyz Bezerra Silva, Eduardo Grecco, Luiz Gustavo de Quadros, André Teixeira, Thiago Souza, Jimi Scarparo, Artur A Parada, Ricardo Dib, Rena Moon, Josemberg Campos
BACKGROUND: Intragastric balloons (IGBs) are a minimally invasive option for obesity treatment, acting as a space-occupying device and leading to weight loss through increased satiety. This device has been growing in popularity owing to its safety profile and good weight loss results. However, there are no published guidelines that standardize the technical aspects of the procedure. OBJECTIVES: To create a practical guideline for intragastric balloon usage. SETTING: Private and Academic Settings, Brazil...
September 28, 2017: Surgery for Obesity and related Diseases: Official Journal of the American Society for Bariatric Surgery
https://www.readbyqxmd.com/read/29090379/response-rates-with-the-spatz3-adjustable-balloon
#3
Eduardo Usuy, Jeffrey Brooks
BACKGROUND: Intragastric balloons (IGBs) have demonstrated efficacy; however, the percent of "responders" (> 25% estimated weight loss (EWL) or > 10% total body weight loss (TBWL)-as suggested by FDA) have been less reported. The Spatz3 adjustable intragastric balloon (AIGB) extends implantation to 1 year, decreases balloon volume for intolerance, and increases volume for diminishing effect. AIM: The aim of this study is to determine the efficacy/responder rate of the Spatz3 AIGB...
October 31, 2017: Obesity Surgery
https://www.readbyqxmd.com/read/29072419/endoscopic-treatment-of-obesity-and-complications-after-bariatric-surgery
#4
Tobias Schlosser, Juergen Feisthammel, Joachim Moessner, Albrecht Hoffmeister
Prevalence and incidence of obesity in the population has been increasing for decades. Due to associated comorbidities, treatment of obesity has become a global health topic and should be addressed with multimodal strategies. As conservative treatment has high rates of failure, bariatric surgery is often performed, especially in cases of severe obesity. However, interventional endoscopic options are gaining importance as less invasive approach. Intragastric balloons and duodenojejunal bypass liners are the most frequent applied endoscopic therapies...
December 2017: Minerva Chirurgica
https://www.readbyqxmd.com/read/29071537/major-gastric-haemorrhage-after-intragastric-balloon-insertion-case-report
#5
Romy J Granek, Michael W Hii, Salena M Ward
Intragastric balloons are a minimally invasive option for weight loss. They are generally well tolerated and rarely associated with serious adverse events. We report a case of major upper gastrointestinal haemorrhage after insertion of an Orbera® intragastric balloon.
October 25, 2017: Obesity Surgery
https://www.readbyqxmd.com/read/29065923/impact-of-6%C3%A2-months-of-treatment-with-intragastric-balloon-on-body-fat-and-quality-of-life-in-obese-individuals-with-metabolic-syndrome
#6
Erika Paniago Guedes, Eduardo Madeira, Thiago Thomaz Mafort, Miguel Madeira, Rodrigo Oliveira Moreira, Laura Maria Carvalho de Mendonça, Amélio Fernando de Godoy-Matos, Agnaldo José Lopes, Maria Lucia Fleiuss Farias
BACKGROUND: Obesity is a worldwide public health issue with a negative impact on quality of life. Different weight loss interventions have demonstrated improvements in quality of life. The aim of this study was to investigate the effect of 6 months of treatment with an intragastric balloon (IGB) on health-related quality of life (HRQOL) and its relation to changes in body fat in obese individuals with metabolic syndrome (MS). METHODS: Fifty obese patients with MS aged 18-50 were selected for treatment with IGB for 6 months...
October 24, 2017: Health and Quality of Life Outcomes
https://www.readbyqxmd.com/read/29017684/mechanical-intestinal-obstruction-caused-by-migration-of-deflated-intragastric-balloon
#7
Erdal Uysal
No abstract text is available yet for this article.
September 2017: Journal of the College of Physicians and Surgeons—Pakistan: JCPSP
https://www.readbyqxmd.com/read/28989057/a-prospective-pilot-study-of-the-efficacy-and-safety-of-elipse-intragastric-balloon-a-single-center-single-surgeon-experience
#8
Saud Al-Subaie, Salman Khalifa, Waleed Buhaimed, Shahad Al-Rashidi
BACKGROUND: Elipse™ is the least invasive IGB for weight loss that needs no sedation or endoscopy. It is a swallowable capsule filled with 550 mL of fluid, which stays in the stomach for 16 weeks and is excreted from the gastrointestinal tract. Kuwait is one of the first countries to start using Elipse™ as a weight loss device. This study aims to evaluate the efficacy and safety of Elipse™ intragastric balloon (IGB). MATERIALS AND METHODS: This is a single-center prospective pilot study of 51 Elipse™ insertions at our clinic...
October 6, 2017: International Journal of Surgery
https://www.readbyqxmd.com/read/28983652/what-the-radiologist-needs-to-know-about-gastrointestinal-endoscopic-surgical-procedures
#9
REVIEW
Chandana Lall, Anastasia A Cruz, Vlad Bura, Adam A Rudd, Thangavijayan Bosemani, Kenneth J Chang
Natural orifice transluminal endoscopic surgery (NOTES) is a novel surgical approach, currently performed for an array of conditions. Endoscopic procedures offer significant benefits, including lower cost, no surgical incisions, and shorter hospital stays. These advantages align with the current trends in health care, namely a push for "cost-effective care." There are a multitude of health issues which are now being addressed by the endoscopic surgical approach, including peroral endoscopic myotomy (POEM), which is a relatively new technique used in the treatment of achalasia...
October 5, 2017: Abdominal Radiology
https://www.readbyqxmd.com/read/28975289/deaths-reported-after-intragastric-balloon-surgery
#10
Rebecca Voelker
No abstract text is available yet for this article.
September 19, 2017: JAMA: the Journal of the American Medical Association
https://www.readbyqxmd.com/read/28965290/endoscopic-treatments-for-obesity
#11
REVIEW
Gregory Pajot, Gerardo Calderon, Andrés Acosta
Purpose of review Endoscopic bariatric therapy (EBT) is a rapidly developing area that has now seen FDA approval of six endoscopic bariatric devices and procedures and there are a number of other novel EBTs progressing through various stages of development with newly published findings. This paper aims to assist readers in either selecting an appropriate therapy for their patient or deciding to incorporate these therapies into their practice. This paper provides an updated review of the available data on EBTs, both FDA approved and not, with a particular focus on effectiveness and safety, as well as guidance for discussing with your patient the decision to use endoscopic therapies...
December 2017: Current Treatment Options in Gastroenterology
https://www.readbyqxmd.com/read/28945697/acute-pancreatitis-a-complication-of-intragastric-balloon
#12
Murad Aljiffry, Razan Habib, Eman Kotbi, Amro Ageel, Mazen Hassanain, Yaser Dahlan
PURPOSE: This study was carried out because intragastric balloon (IGB) is a widely used method to combat obesity, and acute pancreatitis complicating IGB is rare and yet to be understood. METHOD: This study was a retrospective analysis of all patients with a history of IGB insertion, who developed acute pancreatitis before balloon removal. RESULTS: A total of 4 cases were found, with a mean age of 27±2.9 years. The mean duration of IGB insertion was 2...
September 22, 2017: Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
https://www.readbyqxmd.com/read/28881892/influence-of-esophagectomy-on-the-gastroesophageal-reflux-in-patients-with-esophageal-cancer
#13
D Kim, Y W Min, J G Park, H Lee, B-H Min, J H Lee, P-L Rhee, J J Kim, J I Zo
This study aims to assess the influence of esophagectomy with gastric transposition on the gastroesophageal reflux (GER) and gastric acidity in patients with esophageal cancer. Data on 53 esophageal cancer patients who underwent 24-hour impedance-pH monitoring after esophagectomy were retrospectively analyzed. We used a solid-state esophageal pH probe in which the esophageal pH sensor is placed 1.5 cm distal to the upper esophageal sphincter and the gastric pH sensor is located 15 cm distal to the esophageal pH channel...
December 1, 2017: Diseases of the Esophagus: Official Journal of the International Society for Diseases of the Esophagus
https://www.readbyqxmd.com/read/28871497/safety-and-efficacy-of-a-new-swallowable-intragastric-balloon-not-needing-endoscopy-early-italian-experience
#14
A Genco, I Ernesti, R Ienca, G Casella, S Mariani, D Francomano, E Soricelli, M Lorenzo, M Monti
PURPOSE: The aim of this study was to evaluate the safety and efficacy of a new intragastric balloon (Elipse™ Balloon, Allurion Technologies, Natick, MA USA) not needing endoscopy. MATERIALS AND METHODS: The balloon was swallowed under fluoroscopy in 38 consecutive patients (F/M 28/10, mean age 46.4 ± 10.6 years, mean weight 109.7 ± 21.9 kg, and mean body mass index (BMI) 38.6 ± 6.7 kg/m(2)). After 4 months, the balloon spontaneously emptied and it was excreted through the digestive tract without upper endoscopy...
September 4, 2017: Obesity Surgery
https://www.readbyqxmd.com/read/28871150/intragastric-balloon-as-an-adjunct-to-lifestyle-programme-in-severely-obese-adolescents-impact-on-biomedical-outcomes-and-skeletal-health
#15
P Sachdev, L Reece, M Thomson, A Natarajan, R J Copeland, J K Wales, N P Wright
Intragastric Balloons are a temporary, reversible, and safer option compared to bariatric surgery to promote significant weight loss leading to improved metabolic outcomes. However due to subsequent weight regain, alternative procedures are now preferred in adults. In adolescents, more amenable to lifestyle change, balloons may be an alternative to less reversible procedures. Our aim was to assess the tolerability and efficacy of the intragastric balloon in severely obese adolescents and the impact of associated weight loss on biomedical outcomes (glucose metabolism, blood pressure, lipid profiles) and bone density...
September 5, 2017: International Journal of Obesity: Journal of the International Association for the Study of Obesity
https://www.readbyqxmd.com/read/28861806/rutaecarpine-inhibits-intimal-hyperplasia-in-a-balloon-injured-rat-artery-model
#16
Yang Xu, Xiu-Ping Chen, Feng Zhang, Hua-Hua Hou, Jing-Yi Zhang, Shu-Xian Lin, An-Sheng Sun
OBJECTIVE: To investigate the effect and potential mechanisms of rutaecarpine (Rut) in a rat artery balloon-injury model. METHODS: The intimal hyperplasia model was established by rubbing the endothelia with a balloon catheter in the common carotid artery (CCA) of rats. Fifty rats were randomly divided into fifive groups, ie. sham, model, Rut (25, 50 and 75 mg/kg) with 10 rats of each group. The rats were treated with or without Rut (25, 50, 75 mg/kg) by intragastric administration for 14 consecutive days following injury...
September 1, 2017: Chinese Journal of Integrative Medicine
https://www.readbyqxmd.com/read/28759923/a-novel-mechanical-simulator-for-hands-on-bariatric-endoscopy-training-in-intragastric-balloon-placement
#17
Marco A D'Assunçao, Fernando Lander Mota, Lucas S Nova da Costa, Willian Ferreira Igi, Dejan Radenkovic, Alvaro Martinez-Alcalá, Paul T Kröner
No abstract text is available yet for this article.
October 2017: Endoscopy
https://www.readbyqxmd.com/read/28740414/the-role-of-endoscopic-therapy-in-obesity-management-intragastric-balloons-and-aspiration-therapy
#18
REVIEW
Nitin Kumar, Shelby Sullivan, Christopher C Thompson
Weight management is increasingly incorporating endoscopic bariatric therapy (EBT). As the global burden of obesity and its comorbidities has increased, it is evident that novel therapeutic approaches will be necessary to address the obesity epidemic. EBTs offer greater efficacy than diet and lifestyle modification and lower invasiveness than bariatric surgery. The US Food and Drug Administration has approved two intragastric balloons and aspiration therapy for the treatment of obesity: Apollo Orbera is indicated for the treatment of Class I and Class II obesity, Re Shape Integrated Dual Balloon system is indicated for the same range with a comorbidity, and Aspire Bariatrics AspireAssist is approved for patients with a body mass index of 35-55 kg/m(2)...
2017: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
https://www.readbyqxmd.com/read/28731953/assessment-of-weight-loss-with-the-intragastric-balloon-in-patients-with-different-degrees-of-obesity
#19
Gabriel C Nunes, Denis Pajecki, Maria E de Melo, Marcio C Mancini, Roberto de Cleva, Marco A Santo
INTRODUCTION: The intragastric balloon (IGB) is an endoscopic device for the treatment of obesity. Best results are observed in patients who follow a dietary program but few studies have assessed the results of this treatment in patients with different degrees of obesity. AIM: The aim of this study is to compare the efficacy of IGB in patients with different degrees of obesity. METHOD: A total of 2002 patients with IGB were retrospectively evaluated and were divided into groups according to initial body mass index (BMI) range, as follows: group 1, 27 to 29...
August 2017: Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
https://www.readbyqxmd.com/read/28707286/intragastric-balloon-treatment-for-obesity-review-of-recent-studies
#20
REVIEW
Chinara M Tate, Allan Geliebter
INTRODUCTION: The FDA recently approved three intragastric balloon (IGB) devices, ReShape, ORBERA™, and Obalon for treatment of obesity. Given the high cost, complication risk, and invasiveness of bariatric surgery, IGB treatment may present a safer and lower cost option for weight reduction. IGBs are generally placed in the stomach endoscopically for up to 6 months to reduce gastric capacity, enhance feelings of fullness, and induce weight loss. The mechanism of action likely involves stimulation of gastric mechanoreceptors triggering short-acting vagal signals to brain regions implicated in satiety...
August 2017: Advances in Therapy
keyword
keyword
33321
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"